Disparities in the Use of Mechanical Thrombectomy Alone Compared with Adjunctive Intravenous Thrombolysis in Acute Ischemic Stroke in the United States

References

1. 1.↵
   1. Saver JL,
   2. Goyal M,
   3. van der Lugt A, et al

   ; HERMES Collaborators, Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016;316:1279–89 doi:10.1001/jama.2016.13647 pmid:27673305

   CrossRefPubMed
2. 2.↵
   1. Powers WJ,
   2. Rabinstein AA,
   3. Ackerson T, et al

   ; American Heart Association Stroke Council. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–110 doi:10.1161/STR.0000000000000158 pmid:29367334

   CrossRefPubMed
3. 3.↵
   1. Yang P,
   2. Treurniet KM,
   3. Zhang L, et al

   ; DIRECT-MT investigators. Direct Intra-arterial thrombectomy in order to Revascularize AIS patients with large vessel occlusion Efficiently in Chinese Tertiary hospitals: a multicenter randomized clinical trial (DIRECT-MT)—Protocol. Int J Stroke 2020;15:689–98 doi:10.1177/1747493019882837 pmid:31663831

   CrossRefPubMed
4. 4.↵
   1. Suzuki K,
   2. Matsumaru Y,
   3. Takeuchi M, et al

   ; SKIP Study Investigators. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: the SKIP randomized clinical trial. JAMA 2021;325:244–53 doi:10.1001/jama.2020.23522 pmid:33464334

   CrossRefPubMed
5. 5.↵
   1. Zi W,
   2. Qiu Z,
   3. Li F, et al

   ; DEVT Trial Investigators. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial. JAMA 2021;325:234–43 doi:10.1001/jama.2020.23523 pmid:33464335

   CrossRefPubMed
6. 6.↵
   1. Brinjikji W,
   2. Rabinstein AA,
   3. Cloft HJ

   . Socioeconomic disparities in the use of mechanical thrombectomy for acute ischemic stroke. J Stroke Cerebrovasc Dis 2014;23:979–84 doi:10.1016/j.jstrokecerebrovasdis.2013.08.008 pmid:24119620

   CrossRefPubMed
7. 7.↵
   Healthcare Cost and Utilization Project US NIS Overview. https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed June 1, 2021
8. 8.↵
   1. Nogueira RG,
   2. Jadhav AP,
   3. Haussen DC, et al

   . Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11–21 doi:10.1056/NEJMoa1706442 pmid:29129157

   CrossRefPubMed
9. 9.↵
   1. Dávalos A,
   2. Pereira VM,
   3. Chapot R, et al

   . Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke 2012;43:2699–705 doi:10.1161/STROKEAHA.112.663328 pmid:22851547

   Abstract/FREE Full Text
10. 10.↵
    1. Moore BJ,
    2. White S,
    3. Washington R, et al

    . Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser Comorbidity Index. Med Care 2017;55:698–705 doi:10.1097/MLR.0000000000000735 pmid:28498196

    CrossRefPubMed
11. 11.↵
    1. Patel PD,
    2. Salwi S,
    3. Liles C, et al

    . Creation and validation of a stroke scale to increase utility of national inpatient sample administrative data for clinical stroke research. J Stroke Cerebrovasc Dis 2021;30:105658 doi:10.1016/j.jstrokecerebrovasdis.2021.105658 pmid:33588186

    CrossRefPubMed
12. 12.↵
    1. Mehta CR,
    2. Patel NR,
    3. Senchaudhuri P

    . Exact power and sample-size computations for the Cochran-Armitage Trend Test. Biometrics 1998;54:1615–21 doi:10.2307/2533685

    CrossRef
13. 13.↵
    1. Cuzick J

    . A Wilcoxon-type test for trend. Stat Med 1985;4:87–90 doi:10.1002/sim.4780040112 pmid:3992076

    CrossRefPubMedWeb of Science
14. 14.↵
    STATA Statistical Software: Release 16. StataCorp; 2019 https://www.scirp.org/reference/referencespapers.aspx?referenceid=2757660. Accessed June 1, 2021
15. 15.↵
    1. Golnari P,
    2. Nazari P,
    3. Ansari SA, et al

    . Endovascular thrombectomy after large-vessel ischemic stroke: use, outcomes, and readmissions across the United States. Radiology 2021;299:179–89 doi:10.1148/radiol.2021203082 pmid:33591890

    CrossRefPubMed
16. 16.↵
    1. Goyal M,
    2. Menon BK,
    3. van Zwam WH, et al

    . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31 doi:10.1016/S0140-6736(16)00163-X pmid:26898852

    CrossRefPubMed
17. 17.↵
    1. Rinaldo L,
    2. Rabinstein AA,
    3. Cloft H, et al

    . Racial and ethnic disparities in the use of thrombectomy for acute stroke. Stroke 2019;50:2428–32 doi:10.1161/STROKEAHA.118.024651 pmid:31366313

    CrossRefPubMed
18. 18.↵
    1. Nagaraja N,
    2. Olasoji EB,
    3. Patel UK

    . Sex and racial disparity in use and outcomes of t-PA and thrombectomy in acute ischemic stroke. J Stroke Cerebrovasc Dis 2020;29:104954 doi:10.1016/j.jstrokecerebrovasdis.2020.104954 pmid:32807414

    CrossRefPubMed
19. 19.↵
    1. Otite FO,
    2. Saini V,
    3. Sur NB, et al

    . Ten-year trend in age, sex, and racial disparity in tPA (alteplase) and thrombectomy use following stroke in the United States. Stroke 2021;53;2562–70 doi:10.1161/STROKEAHA.120.03213]2 pmid:34078107

    CrossRefPubMed
20. 20.↵
    1. Yang P,
    2. Zhang Y,
    3. Zhang L, et al

    ; DIRECT-MT Investigators. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med 2020;382:1981–93 doi:10.1056/NEJMoa2001123 pmid:32374959

    CrossRefPubMed
21. 21.↵
    DIRECT-SAFE. A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval, https://clinicaltrials.gov/ct2/show/NCT03494920. Accessed June 1, 2021
22. 22.↵
    Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke (SWIFT DIRECT). https://clinicaltrials.gov/ct2/show/NCT03192332, Accessed June 1, 2021
23. 23.↵
    1. Roos Y,
    2. Majoie C

    . Is intravenous alteplase still of added benefit in patients with acute ischaemic stroke who undergo intra-arterial treatment? https://www.isrctn.com/ISRCTN80619088. Accessed June 1, 2021 doi:10.1186/isrctn80619088
24. 24.↵
    1. Rabinstein AA

    . Administrative medical databases for clinical research: the good, the bad, and the ugly. Neurocrit Care 2018;29:323–25 doi:10.1007/s12028-018-0625-6 pmid:30302672

    CrossRefPubMed
25. 25.↵
    1. Sussman ES,
    2. Jin M,
    3. Pendharkar AV, et al

    . Dual antiplatelet therapy after carotid artery stenting: trends and outcomes in a large national database. J Neurointerv Surg 2021;13:8–13 doi:10.1136/neurintsurg-2020-016008 pmid:32414894

    Abstract/FREE Full Text
26. 26.↵
    1. Kuybu O,
    2. Javalkar V,
    3. Amireh A, et al

    . Implications of the use of mechanical thrombectomy on outcome in large vessel occlusion following the 2015 landmark trials. J Neurointerv Surg 2021;13:4–7 doi:10.1136/neurintsurg-2020-015903 pmid:32381521

    Abstract/FREE Full Text
27. 27.↵
    1. Munich SA,
    2. Vakharia K,
    3. Levy EI

    . Overview of mechanical thrombectomy techniques. Neurosurgery 2019;85:S60–67 doi:10.1093/neuros/nyz071 pmid:31197338

    CrossRefPubMed